Goldman Sachs Commodity Index Futures (GSCI)) (GD May 2025)/ XFTTGDCMEGLB / CME GLOBEX
GD| 4/17/2025 6:05:18 PM | Chg. +7.2000 | Bid11:00:00 PM | Ask11:00:00 PM | Open | High | Low | Previous Close |
|---|---|---|---|---|---|---|---|
| 538.4500USD | +1.36% | 537.1000 | 539.4500 | 535.6000 | 538.4500 | 534.3000 | 531.2500 |
GlobeNewswire
4/10
Surge In Global Defense Budgets Having Significant Impact On The Global Military (UAS) Drone Market
GlobeNewswire
4/10
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Acade...
GlobeNewswire
4/8
Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progres...
GlobeNewswire
4/8
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Acade...
GlobeNewswire
4/7
TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals
GlobeNewswire
4/3
Fitell Corporation Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement
GlobeNewswire
4/3
Vera Therapeutics Completes Full Enrollment in Pivotal ORIGIN Phase 3 Trial for Atacicept in IgAN
GlobeNewswire
4/1
GD Culture Group Limited Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficie...
GlobeNewswire
3/26
Fitell Corporation Announces that it will hold its Extraordinary General Meeting of Shareholders on ...
GlobeNewswire
3/25
Press Release: Tolebrutinib regulatory submission accepted for priority review in the US for patient...
GlobeNewswire
3/13
Goliath Resources Updated Modelling Confirms Its Large Gold Rich Layered System Is Directly Associat...
GlobeNewswire
3/11
AMD Unveils 5th Gen AMD EPYC Embedded Processors Delivering Leadership Performance, Efficiency and L...
GlobeNewswire
3/7
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Scle...
GlobeNewswire
2/28
AMD Unveils Next-Generation AMD RDNA™ 4 Architecture with the Launch of AMD Radeon™ RX 9000 Series G...
GlobeNewswire
2/27
TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Co...
GlobeNewswire
2/26
Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial R...
GlobeNewswire
2/18
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Scle...
GlobeNewswire
2/18
Goliath Drills 10.91 g/t AuEq Over 10.00 Meters Including 15.51 g/t AuEq Over 7.00 Meters And Discov...
GlobeNewswire
2/10
Fitell Corporation Announces Closing of Registered Direct Offering for up to $10.0 Million
GlobeNewswire
2/10
Fitell Corporation Announces Updated Registered Direct Offering for up to $10.0 Million
